Document Type : Review

Authors

• Shaghayegh Rahmani ¹
• Farideh Namvar ²
• Ali khakshour ³
• Roohie Farzaneh ⁴
• Fateme Tara ⁵
• Rana kolahi ahari ⁶

¹ Clinical Research Development Center, 22 Bahman Hospital, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran

² Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.

³ Pediatrics Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

⁴ Emergency Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

⁵ Gynecologist.Felloship in Perinatology. Mathercare Reseach Center.Omolbanin Hospital.Mashad University of Mdical Sciences.Mashad.Iran

⁶ linical Research Development Center, 22 Bahman Hospital, Faculty of Medicine, Mashhad Medical Sciences, Islamic Azad University, Mashhad, Iran.

Abstract

According to the World Health Organization (2022), severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is liable for more than 572 million cases worldwide and more than six million deaths globally. It has been reported that pregnancy can change the disease manifestations such that gastrointestinal symptoms, which are common in pregnant women, are difficult to distinguish from COVID-19 related complications. Hence, in isolated cases of gastrointestinal or liver forms of COVID-19, diagnosis might be delayed. Previous studies have suggested that serious complications of COVID-19 in pregnancy are associated with a higher body mass index (BMI), gestational diabetes, and older age; thus, this population should be considered as high risk. In this article, we summarized previously published evidence about pregnant women with COVID‐19 and liver dysfunction.

Keywords

• Pregnancy
• COVID-19
• Liver dysfunction